Grundläggande statistik
| CIK | 96793 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to SunLink Health Systems, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-12607 SunLink Health Systems, Inc. (Exact name of registrant as specifie |
|
| August 15, 2025 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES NYSE American LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 26, 2025, pursuant to the provisions of Rule 12d2-2 (a). |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration Statement No. |
|
| August 14, 2025 |
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Complete Merger Exhibit 99.1 Regional Health Properties, Inc. and SunLink Health Systems, Inc. Complete Merger Atlanta, GA (August 14, 2025) - Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) today announced the completion of the merger of SunLink Health Systems, Inc. (“SunLink”) with and into Regional, with Regional surviving the merger as the surviving corporation, effective August 14, |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration Statement No. |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 14, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Em |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emp |
|
| August 5, 2025 |
Exhibit 99.1 Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger Atlanta, GA (August 4, 2025) - Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that, at special meetings of their respective shareholders each held on |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 29, 2025 |
Exhibit 99.1 SunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger with Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDT Atlanta, GA (July 29, 2025) - SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink convened its special meeting (the |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 24, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 24, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 25, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDT Over 99% of the SunLink shares voted |
|
| July 24, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SunLink Health Systems, Inc. provides update on Special Cash Dividend scheduled to be paid prior to SunLink’s proposed merger with Regional Health Properties, Inc. ATLANTA, Georgia (July 24, 2025) – SunLink Health Systems, Inc. (NYSE American: SSY) today issued the following upda |
|
| July 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Em |
|
| July 24, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Em |
|
| July 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 18, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| July 8, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SunLink Health Systems announces that it received a NYSE American LLC notice indicating that SunLink has fallen below certain NYSE American continued listing standards because it failed to hold its annual meeting of stockholders for the fiscal year ending on June 30, 2025, as set |
|
| July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emplo |
|
| July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emplo |
|
| July 8, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SunLink Health Systems announces that it received a NYSE American LLC notice indicating that SunLink has fallen below certain NYSE American continued listing standards because it failed to hold its annual meeting of stockholders for the fiscal year ending on June 30, 2025, as set |
|
| June 25, 2025 |
SUNLINK HEALTH SYSTEMS, INC. 900 Circle 75 Parkway, Suite 690 Atlanta, Georgia 30339 Filed by SunLink Health Systems, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SunLink Health Systems, Inc. Commission File No. 001-12607 File No. of Related Registration Statement: 333-286975 Date: June 25, 2025 SUNLINK HEALTH SYSTEMS, INC. 900 Circle 75 Parkway, Suite 690 Atlanta, |
|
| June 25, 2025 |
REGIONAL HEALTH PROPERTIES, INC. 1050 Crown Pointe Parkway, Suite 720 Atlanta, Georgia 30338 Filed by Regional Health Properties, Inc. (Commission File No. 001-33135) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Form S-4, File No. 333-286975 Subject Company: SunLink Health Systems, Inc. (Commission File No. 001-12607) Date: June 25, 2025 REGIONAL HEALTH PROPERTIES, INC. 1050 Crown Pointe Parkwa |
|
| June 25, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul |
|
| June 23, 2025 |
AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER Exhibit 2.1 AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER This AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER, dated as of June 22, 2025 (this “Amendment”), is by and between Regional Health Properties, Inc., a Georgia corporation (“Regional”), and SunLink Health Systems, Inc., a Georgia corporation (“SunLink” and, together with Regional, the “Parties” and each, a |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 22, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| June 23, 2025 |
AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER Exhibit 2.1 AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER This AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER, dated as of June 22, 2025 (this “Amendment”), is by and between Regional Health Properties, Inc., a Georgia corporation (“Regional”), and SunLink Health Systems, Inc., a Georgia corporation (“SunLink” and, together with Regional, the “Parties” and each, a |
|
| June 23, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 22, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Empl |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 1. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| April 18, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emp |
|
| April 18, 2025 |
Exhibit 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and between REGIONAL HEALTH PROPERTIES, INC. and SUNLINK HEALTH SYSTEMS, INC. Dated as of April 14, 2025 TABLE OF CONTENTS ARTICLE I 2 THE MERGER 2 1.1. The Merger 2 1.2. Effective Time of the Merger 2 1.3. Closing 2 1.4. Effects of the Merger 3 1.5. Directors and Officers; Regional Special Committee 3 1.6. Conversion of Capital Stoc |
|
| April 18, 2025 |
Exhibit 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and between REGIONAL HEALTH PROPERTIES, INC. and SUNLINK HEALTH SYSTEMS, INC. Dated as of April 14, 2025 TABLE OF CONTENTS ARTICLE I 2 THE MERGER 2 1.1. The Merger 2 1.2. Effective Time of the Merger 2 1.3. Closing 2 1.4. Effects of the Merger 3 1.5. Directors and Officers; Regional Special Committee 3 1.6. Conversion of Capital Stoc |
|
| April 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emp |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emp |
|
| April 15, 2025 |
REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION Exhibit 99.1 REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION Atlanta, GA (April 15, 2025) - Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the “merger agreeme |
|
| April 15, 2025 |
REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION Exhibit 99.1 REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION Atlanta, GA (April 15, 2025) - Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the “merger agreeme |
|
| April 15, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Emp |
|
| February 21, 2025 |
EX-99.1 2 ex991to13g09076ssy022125.htm JOINT FILING AGREEMENT Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that the Statement on Schedule 13G dated February 21, 2025, with respect to the Common Shares, without par value, of SunLink Health Systems, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pur |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| January 10, 2025 |
Exhibit 10.1 REGIONAL SHAREHOLDER SUPPORT AND LOCK-UP AGREEMENT This Regional Shareholder Support and Lock-up Agreement (this “Agreement”) is dated as of January 3, 2025, by and among REGIONAL HEALTH PROPERTIES, INC., a Georgia corporation (“Regional”), SUNLINK HEALTH SYSTEMS, INC., a Georgia corporation (“SunLink”), and the Persons set forth on Schedule I hereto (each, a “Regional Shareholder” an |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 1-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 1-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 10, 2025 |
Exhibit 10.2 SUNLINK SHAREHOLDER SUPPORT AND LOCK-UP AGREEMENT This SunLink Shareholder Support and Lock-up Agreement (this “Agreement”) is dated as of January 3, 2025, by and among REGIONAL HEALTH PROPERTIES, INC., a Georgia corporation (“Regional”), SUNLINK HEALTH SYSTEMS, INC., a Georgia corporation (“SunLink”), and the Persons set forth on Schedule I hereto (each, a “SunLink Shareholder” and, |
|
| January 10, 2025 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and between REGIONAL HEALTH PROPERTIES, INC. and SUNLINK HEALTH SYSTEMS, INC. Dated as of January 3, 2025 TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER 1 ARTICLE I 2 THE MERGER 2 1.1. The Merger 2 1.2. Effective Time of the Merger 2 1.3. Closing 2 1.4. Effects of the Merger 3 1.5. Directors and Officers; Regional Special Committee 3 1.6. Conversion of C |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. |
|
| January 6, 2025 |
Exhibit 99.1 REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS TO MERGE IN AN ALL-STOCK TRANSACTION Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA (January 6, 2025) - Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA) |
|
| January 6, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2025 SunLink Health Systems, Inc. (Exact Name of Registrant as Specified in its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of (Commission (I.R.S. Em |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K/A ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exa |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commis |
|
| October 18, 2024 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SALE OF TRACE REGIONAL HOSPITAL REAL ESTATE EXHIBIT 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SALE OF TRACE REGIONAL HOSPITAL REAL ESTATE Atlanta, GA (October 10, 2024) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have comple |
|
| October 18, 2024 |
Exhit 10.1 AMENDED AND RESTATED REAL ESTATE PURCHASE AGREEMENT BY AND Between SOUTHERN HEALTH CORPORATION of Houston, Inc. AND EAST MADISON PROPERTY LLC COLLECTIVELY, AS SELLER AND PROGRESSIVE HEALTH OF HOUSTON, LLC AS BUYER September 9, 2024 TABLE OF CONTENTS 1.Agreement to Sell and to Purchase.2 1.1 Purchase of Trace Real Property2 1.2 Purchase Price2 1.3 Prorations3 1.4 Environmental Report3 1. |
|
| September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| September 30, 2024 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 30, 2024 |
SunLink Healthcare Systems, Inc. Incentive-Based Compensation Recovery (Clawback) Policy. Exhibit 97.1 SUNLINK HEALTHCARE SYSTEMS, INC. POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Adopted as of November 1, 2023 1. Purpose. The purpose of this Policy is to describe the circumstances in which Executive Officers will be required to repay or return Erroneously Awarded Compensation to members of the Company Group. The Policy applies to all Incentive-Based Compensation receiv |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| July 12, 2024 |
Howard E. Turner July 11, 2024 EXHIBIT 99.1 Howard E. Turner July 11, 2024 Mr. Robert M. Thornton, Jr. Chairman, President and Chief Executive Officer SunLink Health Systems, Inc. 900 Circle 75 Parkway, Suite 690 Atlanta, GA 30339 In Re: Resignation from the Board of Directors of SunLink Health Systems, Inc. ("SunLink") Dear Bob: I hereby voluntarily resign as a Director of SunLink effective immediately as of this 11th day of J |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| June 6, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted |
|
| June 5, 2024 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SALE OF TRACE EXTENDED CARE & REHAB EXHIBIT 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SALE OF TRACE EXTENDED CARE & REHAB Atlanta, GA (June 3, 2024) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Exten |
|
| June 5, 2024 |
EXECUTION COPY EXHIBIT 10.1 ASSET PURCHASE AGREEMENT BY AND AMONG SOUTHERN HEALTH CORPORATION OF HOUSTON, INC. (“SOUTHERN”) AND EAST MADISON PROPERTY, LLC (“EMP”), AS SELLERS AND KELLY HOLDINGS HOUSTON, LLC (“KELLY HOLDINGS”), AND TREND HEALTH AND REHAB OF HOUSTON, LLC (“TREND OF HOUSTON”), AS BUYERS MAY 31, 2024 TABLE OF CONTENTS 1. PURCHASE OF PURCHASED ASSETS 2 Section 1.1 Purchased Assets 2 Se |
|
| June 5, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2024 SunLink Health Systems Inc. (Exact Name of Registrant as Specified in Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| May 23, 2024 |
Amendment No. 1 to Bylaws of SunLink Health Systems, Inc EXHIBIT 3(ii) AMENDED AND RESTATED BYLAWS OF SUNLINK HEALTH SYSTEMS, INC. Table of Contents Page ARTICLE 1 OFFICES AND AGENT Section 1.1 Registered Office and Agent 1 Section 1.2 Other Offices 1 ARTICLE 2 MEETINGS OF SHAREHOLDERS Section 2.1 Annual Meetings 1 Section 2.2 Special Meetings 1 Section 2.3 Place of Meetings 1 Section 2.4 Notice of Meetings 1 Section 2.5 Voting Group 2 Section 2.6 Quoru |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10,2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commission |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| January 29, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commis |
|
| January 29, 2024 |
Exhibit 10.1 Asset PURCHASE AGREEMENT BY AND Between SOUTHERN HEALTH CORPORATION of Houston, Inc. (“Seller”), AND PROGRESSIVE HEALTH OF HOUSTON, LLC (“Buyer”) January 22, 2024 TABLE OF CONTENTS 1. Purchase of Trace Regional Assets; Purchase Price; Etc. 1 1.1 Purchase of Trace Regional Assets 1 1.2 Trace Regional Assets 1 1.3 Excluded Assets 3 1.4 Buyer Assumed Liabilities 4 1.5 Seller Retained Lia |
|
| January 29, 2024 |
Exhibit 10.3 LEASE BETWEEN SOUTHERN HEALTH CORPORATION OF HOUSTON, INC. as Lessor AND PROGRESSIVE HEALTH OF HOUSTON, LLC as Lessee Dated as of January 22, 2024 TABLE OF CONTENTS 1. Lease to Lessee. 1 1.1 Lease of Lease Premises 1 1.2 Rent 1 1.3 Net Lease 2 1.4 Prorations 2 1.5 Environmental Report 2 2. Lease Term; Commencement of Lease Term. 3 2.1 Actions of Lessor at Lease Commencement 3 2.2 Acti |
|
| January 29, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS’ SUBSIDIARY REACHES REVISED AGREEMENTS FOR THE SALE OF TRACE REGIONAL MEDICAL CENTER AND CLINICS Atlanta, GA (January 29, 2024) – – SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation |
|
| January 29, 2024 |
Exhibit 10.4 MANAGEMENT AGREEMENT This Management Agreement (“Agreement”) is entered into this 22nd day of January 2024 (the “Effective Date”), by and between, Progressive Health of Houston, LLC, a Mississippi limited liability company (“Company”), with a business address of 265 North Lamar Blvd., Suite C, Oxford MS 38655, and Southern Health Corporation of Houston, Inc., a Georgia corporation (“C |
|
| January 29, 2024 |
Exhibit 10.2 REAL ESTATE PURCHASE AGREEMENT BY AND Between SOUTHERN HEALTH CORPORATION of Houston, Inc. (“Seller”), AND PROGRESSIVE HEALTH OF HOUSTON, LLC (“Buyer”) January 22, 2024 TABLE OF CONTENTS 1. Agreement to Sell and to Purchase. 1 1.1 Purchase of Trace Real Property 1 1.2 Purchase Price 2 1.3 Prorations 2 1.4 Environmental Report 2 1.5 Title Commitment 2 1.6 Post-Execution Due Diligence 2 |
|
| December 12, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commi |
|
| December 12, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. AND PROGRESSIVE HEALTH GROUP, LLC, AGREE TO EXTEND THE CLOSING DATE OF THEIR PREVIOUSLY-ANNOUNCED SALE OF TRACE REGIONAL MEDICAL CENTER. Atlanta, GA (December 12, 2023) SunLink Health Systems, Inc. (“SunLink”) (NYSE: American: SSY) today announced tha |
|
| November 17, 2023 |
EXHIBIT 10.1 EXECUTION VERSION STOCK PURCHASE AGREEMENT BY AND Between Crown Healthcare Investments, LLC (“Seller”), AND Progressive HEALTH GROUP, LLC (“Buyer”) November 10, 2023 TABLE OF CONTENTS 1. Purchase of Shares; Purchase Price; Etc. 1 1.1 Purchase of Shares 1 1.2 Assets 1 1.3 Excluded Assets 3 1.4 Retained Liabilities 4 1.5 Assumed Liabilities 4 1.6 Environmental Report 6 1.7 Prorations 6 |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For th |
|
| November 14, 2023 |
SUNLINK HEALTH SYSTEMS REACHES AGREEMENT FOR SALE OF TRACE REGIONAL MEDICAL CENTER Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS REACHES AGREEMENT FOR SALE OF TRACE REGIONAL MEDICAL CENTER Atlanta, GA (November 13, 2023) – – SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressi |
|
| November 14, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 13, 2023 |
SSY / Sunlink Health Systems Inc / Thornton Robert M Jr - SC 13D/A Activist Investment SC 13D/A 1 d348050dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Robert M. Thornton, Jr. 900 Circle 75 Parkway, Suite 690 Atlanta, Georgia 30339 (770) 933-7000 (N |
|
| October 24, 2023 |
Certificate of Conversion of SunLink Health Systems, Inc. Exhibit 3.2 Control Number : K845382 STATE OF GEORGIA Secretary of State Corporations Division 313 West Tower 2 Martin Luther King, Jr. Dr. Atlanta, Georgia 30334-1530 CERTIFICATE OF CONVERSION I, Brad Raffensperger, the Secretary of State and the Corporation Commissioner of the State of Georgia, hereby certify under the seal of my office that articles of conversion have been filed on 10/23/2023 c |
|
| October 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-12607 SunLink Health Systems, Inc. (Exact name of registrant as specified i |
|
| October 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 23, 2023 SunLink Health Systems Inc. (Exact Name of Registrant as Specified in Charter) Georgia 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commission |
|
| October 24, 2023 |
Exhibit 3.1 DATE DOCUMENT ID DESCRIPTIONFILINGEXPEDCERTCOPY 10/20/2023202329302902Converting Out To Unlicensed Foreign Corp (VXF)99.00300.000.000.00 Receipt This is not a bill. Please do not remit payment. NATIONAL SERVICE INFORMATION. INC. 145 BAKER STREET MARION, OH 43302 I STATE OF OHIOI CERTIFICATE Ohio Secretary of State, Frank LaRose 281540 It is hereby certified that the Secretary of State |
|
| September 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| September 28, 2023 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for use of the Commission Only (as permitted by Rule |
|
| August 11, 2023 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SUNLINK HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Ohio 81-5166048 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 SunLink Health Systems Inc. (Exact Name of Registrant as Specified in Charter) Ohio 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 8, 2023 |
Exhibit 99.1 NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES DIVIDEND OF FRACTIONAL INTERESTS IN SERIES C REDEEMABLE PREFERRED SHARES TO HOLDERS OF ITS COMMON SHARES ATLANTA, Georgia (August 8, 2023) – SunLink Health Systems, Inc. (NYSE American: SSY) today announced that its Board of Directors (a) declared a dividend of o |
|
| August 8, 2023 |
Certificate of Amendment Establishing Series C Redeemable Preferred Shares Exhibit 3.1 AMENDMENT TO ARTICLES OF INCORPORATION OF SUNLINK HEALTH SYSTEMS, INC. Robert M. Thornton, Jr., President and Chief Executive Officer of SUNLINK HEALTH SYSTEMS, INC., an Ohio corporation (the “Corporation”), hereby certifies that, at a meeting of the Board of Directors of the Corporation, duly called and held on the 2nd day of August, 2023 at which a quorum of such directors was presen |
|
| July 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 20, 2023 SunLink Health Systems Inc. (Exact Name of Registrant as Specified in Charter) Ohio 001-12607 31-0621189 (State or Other Jurisdiction (Commission (I.R.S. Employer of Inc |
|
| July 24, 2023 |
EXHIBIT 99.1 NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES THE ELECTION OF MARK J. STOCKSLAGER AS DIRECTOR TO BOARD OF DIRECTORS. On July 20, 2023, the board of directors (the “Board”) of SunLink Health Systems, Inc. (“SSY,” the “Company,” we,” “us” or “our”) filled a vacant seat on the Board of Directors by electing Mar |
|
| July 24, 2023 |
SSY / Sunlink Health Systems Inc / Thornton Robert M Jr - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Robert M. Thornton, Jr. 900 Circle 75 Parkway, Suite 690 Atlanta, Georgia 30339 (770) 933-7000 (Name, Address and Telephone Num |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| February 15, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2023 SunLink Health Systems Inc. (Exact name of Registrant as Specified in Its Charter) Ohio 001-12607 31-0621189 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| February 15, 2023 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL 2023 SECOND QUARTER RESULTS Exhibit 99.1 NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL 2023 SECOND QUARTER RESULTS ATLANTA, Georgia (February 15, 2023) – SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,052,000 ($0.29 per fully diluted share) for its second fiscal quarter ended Decem |
|
| February 15, 2023 | ||
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| November 15, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2022 SUNLINK HEALTH SYSTEMS, INC. (Exact Name of Registrant as Specified in Charter) Ohio 1-12607 31-0621189 (State or other jurisdiction of incorporation) (Commission |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| September 30, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ????Preliminary Proxy Statement ????Confidential, for Use of the Commission Only ???(as permitted by |
|
| September 28, 2022 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| November 15, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2021 SUNLINK HEALTH SYSTEMS, INC. (Exact Name of Registrant as Specified in Charter) Ohio 1-12607 31-0621189 (State or other jurisdiction of incorporation) (Commission |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| September 28, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ????Preliminary Proxy Statement ????Confidential, for Use of the Commission Only ???(as permitted by |
|
| September 27, 2021 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| May 24, 2021 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Howard E. Turner Smith, Gambrell & Russell, LLP 1230 Peachtree Street, Suite 3100 Promenade Atlanta, GA 30309 (404) 815-3594 (N |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| May 14, 2021 |
Exhibit 3(i) CERTIFICATE Of AMENDED ARTICLES OF INCORPORATION Of KRUG INTERNATIONAL CORP. |
|
| March 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 1)1 SunLink Health Systems, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 86737U102 (CUSIP Number) Milton C, Ault III AUL |
|
| March 17, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) March 15, 2021 SUNLINK HEALTH SYSTEMS, INC. (Exact Name of Registrant as Specified in Charter) Ohio 1-12607 31-0621189 (State or other jurisdiction of Incorporation) (Commission Fi |
|
| March 17, 2021 |
EXHIBIT 99.1 NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES $2 MILLION EXPANSION, CAPITAL AND OPERATING IMPROVEMENTS AT TRACE REGIONAL HOSPITAL ATLANTA, Georgia (March 15, 2021) – SunLink Health Systems, Inc. (NYSE American: SSY) announced today that its wholly-owned subsidiary, Trace Regional Hospital, has implemented it |
|
| March 1, 2021 |
SC 13D 1 m228210sc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 SunLink Health Systems, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 86737U102 (CUSIP Numbe |
|
| February 23, 2021 |
10 Cliveden Place London SW1W 8LA EX-99.1 Exhibit 99.1 10 Cliveden Place London SW1W 8LA 22nd February, 2021 R. Thornton Esq., Chairman & CEO SunLink Health Systems Inc. 900 Circle 75 Pkwy., Suite 1120 Atlanta, GA 30339 Dear Bob, Please accept with immediate effect my resignation from the Board of Sunlink Health Systems Inc. It is sad it didn’t work out better but I know you and the rest of the Board have done your best to build v |
|
| February 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) February 22, 2021 SUNLINK HEALTH SYSTEMS, INC. (Exact Name of Registrant as Specified in Charter) Ohio 1-12607 31-0621189 (State or other jurisdiction of Incorporation) (Commission |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, No Par Value (Title of Class of Securities) 86737U102 (CUSIP Number) February 8, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 11, 2021 |
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, No Par Value (Title of Class of Securities) 86737U102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| November 13, 2020 |
- 8-K SHAREHOLDER MEETING 11.13.2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2020 SUNLINK HEALTH SYSTEMS, INC. (Exact name of registrant as specified in charter) Ohio 1-12607 31-0621189 (State or other jurisdiction of incorporation) (Commission |
|
| November 13, 2020 |
Exhibit 10.1 PERSONAL AND CONFIDENTIAL October 1, 2020 Ms. Sheila Brockman Dear Sheila: Please accept this as a formal offer of employment by SunLink Health Systems, Inc. (the “Company” or “SunLink”) effective October 1, 2020 as Vice President of SunLink. Your duties and responsibilities will be as assigned from time to time by SunLink’s CEO or Board of Directors. You will earn a salary of $13,000 |
|
| September 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| September 29, 2020 |
EXHIBIT 10.12 U.S. Small Business Administration NOTE SBA Loan # 41704071-06 SBA Loan Name SOUTHERN HEALTH CORPORATION OF HOUSTON, INC. Date Loan Amount 1700405.02 Interest Rate 1.00% FIXED Borrower SOUTHERN HEALTH CORPORATION OF HOUSTON, INC. Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of One Milli |
|
| September 29, 2020 |
EXHIBIT 10.8 U.S. Small Business Administration NOTE SBA Loan # 9613657702 SBA Loan Name SUNLINK SCRIPTSRX, LLC Date 5/1/2020 Loan Amount 23091.72 Interest Rate 1.00% FIXED Borrower SUNLINK SCRIPTSRX, LLC Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of Twenty Three Thousand Ninety One and 72/100 Doll |
|
| September 29, 2020 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 29, 2020 |
EXHIBIT 10.11 U.S. Small Business Administration NOTE SBA Loan # 42801771-10 SBA Loan Name SUNLINK HEALTH SYSTEMS TECHNOLOGY INC Date 4/13/2020 Loan Amount 149530.00 Interest Rate 1.00% FIXED Borrower SUNLINK HEALTH SYSTEMS TECHNOLOGY INC Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of One Hundred Fo |
|
| September 29, 2020 |
EXHIBIT 10.10 U.S. Small Business Administration NOTE SBA Loan # 43097571-01 SBA Loan Name CROWN HEALTHCARE INVESTMENTS, LLC Date 4/13/2020 Loan Amount 25407.00 Interest Rate 1.00% FIXED Borrower CROWN HEALTHCARE INVESTMENTS, LLC Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of Twenty Five Thousand Fo |
|
| September 29, 2020 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 29, 2020 |
EXHIBIT 10.9 U.S. Small Business Administration NOTE SBA Loan # 49050671-02 SBA Loan Name SUNLINK HEALTH SYSTEMS INC Date 4/14/2020 Loan Amount 88842.00 Interest Rate 1.00% FIXED Borrower SUNLINK HEALTH SYSTEMS INC Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of Eighty Eight Thousand Eight Hundred Fo |
|
| September 29, 2020 |
EXHIBIT 3.1(i) Amended July 22 and 24, 1986; August 17, 1990; July 16, 1996; and August 20, 2001 SUNLINK HEALTH SYSTEMS, INC. CODE OF REGULATIONS ARTICLE I Office The principal office of the Corporation shall be located in the City of Dayton, Montgomery County, Ohio. ARTICLE II Meeting of Shareholders Section 1. Annual Meeting. The annual meeting of the shareholders of the Corporation for the purp |
|
| September 29, 2020 |
EXHIBIT 10.7 U.S. Small Business Administration NOTE SBA Loan # 9738687704 SBA Loan Name CARMICHAEL'S CASHWAY PHARMACY, INC. Date 5/2/2020 Loan Amount 1246682.07 Interest Rate 1.00% FIXED Borrower CARMICHAEL'S CASHWAY PHARMACY, INC. Operating Company N/A Lender Synovus Bank 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of One Million Two Hund |
|
| June 2, 2020 |
SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Nu |
|
| June 2, 2020 |
Press Release announcing expiration of Share Repurchase Program dated June 2, 2020. Exhibit (a)(5)(F) Exhibit (a)(5)(F) FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| March 26, 2020 |
SSY / SunLink Health Systems, Inc. SC 13E3/A - - SC 13E3/A SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Nu |
|
| March 26, 2020 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) March 24, 2020 SUNLINK HEALTH SYSTEMS, INC. (Exact Name of Registrant as Specified in Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission Fi |
|
| March 26, 2020 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SUSPENSION OF SHARE REPURCHASE PROGRAM Exhibit 99.1 FOR IMMEDIATE RELEASENEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES SUSPENSION OF SHARE REPURCHASE PROGRAM Atlanta, Georgia (March 25, 2020) – SunLink Health Systems, Inc. (NYSE American: SSY) announced today that it is suspending its Share Repurchase Program in light of the COVID-19 pandemic. SunLink’s manag |
|
| February 18, 2020 |
SSY / SunLink Health Systems, Inc. SC 13E3/A - - SC 13E3/A SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Nu |
|
| February 13, 2020 |
Quarter Ended December 31, 2019; Filed on February 13, 2020. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| January 31, 2020 |
SSY / SunLink Health Systems, Inc. SC 13E3/A - - SC 13E3/A SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Nu |
|
| January 31, 2020 |
Press Release announcing extension of the Expiration Time dated January 31, 2020 EX-99.(a)(5)(D) Exhibit (a)(5)(D) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES EXTENSION OF SHARE REPURCHASE PROGRAM TO REPURCHASE UP TO $750,000 OF ITS COMMON SHARES THROUGH OPEN MARKET TRANSACTIONS AT PREVAILING MARKET PRICES Atlanta, Georgia (January 31, 2020) – SunLink Health Systems, Inc. (NYSE American: SSY) today announce |
|
| November 15, 2019 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SCHEDULE 13E-3 AMENDMENT NO. 3 Schedule 13E-3 Amendment No. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities |
|
| November 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTE |
|
| November 13, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2019 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission |
|
| October 28, 2019 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SCHEDULE 13E-3 AMENDMENT NO. 2 Schedule 13E-3 Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities |
|
| October 28, 2019 |
Exhibit (a)(3)(A) Exhibit (a)(3)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE “EXPIRATION TIME”). SunLink Health Systems, Inc., an Ohio corporation (the “Company,” “SunLink,” “ |
|
| October 25, 2019 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SCHEDULE 13E-3 AMENDMENT NO. 1 Schedule 13E-3 Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities |
|
| October 25, 2019 |
Notice of Share Repurchase Program, dated October 25, 2019. Exhibit (a)(3)(A) Exhibit (a)(3)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE “EXPIRATION TIME”). SunLink Health Systems, Inc., an Ohio corporation (the “Company,” “SunLink,” “ |
|
| October 17, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASENEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC ANNOUNCES FORM 13e-3 FILING AND NOTICE TO SHAREHOLDERS IN CONNECTION WITH IT’S SHARE REPURCHASE PLAN Atlanta, GA (October 17, 2019) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that it has filed with the Securities and Exchange |
|
| October 17, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) October 17, 2019 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission |
|
| October 16, 2019 |
Notice of Share Repurchase Program, dated October 15, 2019. Exhibit (a)(1)(A) Exhibit (a)(1)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE EXPIRATION TIME). SunLink Health Systems, Inc., an Ohio corporation (the Company, SunLink, |
|
| October 16, 2019 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SCHEDULE 13E-3 Schedule 13E-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) SUNLINK HEALTH SYSTEMS, INC. (Name of the Issuer) SUNLINK HEALTH SYSTEMS, INC. (Names of Persons Filing Statement) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSI |
|
| October 11, 2019 |
SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SHARE REPURCHASE PLAN AND DEBT PAYDOWN Exhibit 99.1 FOR IMMEDIATE RELEASENEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SHARE REPURCHASE PLAN AND DEBT PAYDOWN Atlanta, GA (October 8, 2019) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its Board of Directors had approved a share repurchase program that authorizes the Company to expen |
|
| October 11, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) October 8, 2019 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission F |
|
| September 27, 2019 |
DEF 14A 1 d808865ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the |
|
| September 27, 2019 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corpora |
|
| September 27, 2019 |
Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of June 30, 2019, SunLink Health Systems, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) our Common Stock; and (ii) our Preferred Share Purchase Rights. Description of Common S |
|
| September 27, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, Inc. (Exact |
|
| September 27, 2019 |
SSY / SunLink Health Systems, Inc. / Thornton Robert M Jr - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Robert M. Thornton, Jr. 900 Circle 75 Parkway, Suite 1120 Atlanta, Georgia 30339 (770) 933-7000 (Name, Address and Telephone Nu |
|
| May 14, 2019 |
Quarter Ended March 31, 2019; Filed on May 14, 2019. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEMS, |
|
| March 20, 2019 |
SUNLINK HEALTH SYSTEMS, INC. COMPLETES SALE OF PARKSIDE ELLIJAY NURSING HOME AND REAL ESTATE Exhibit 99.1 FOR IMMEDIATE RELEASENEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. COMPLETES SALE OF PARKSIDE ELLIJAY NURSING HOME AND REAL ESTATE Atlanta, GA (March 19, 2019) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Ellijay, Inc., has completed the sale |
|
| March 20, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) March 19, 2019 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission Fi |
|
| March 4, 2019 |
Exhibit 99.1 . FOR IMMEDIATE RELEASENEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES AGREEMENT FOR SALE OF PARKSIDE ELLIJAY NURSING HOME AND REAL ESTATE Atlanta, GA (February 28, 2019) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Ellijay, Inc., has |
|
| March 4, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2019 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commission |
|
| March 4, 2019 |
Exhibit 99.2 ASSET PURCHASE AGREEMENT BY AND BETWEEN SOUTHERN HEALTH CORPORATION OF ELLIJAY, INC. (“SELLER”), PARKSIDE PROPERTY COMPANY LLC (“BUYER”), PARKSIDE LESSOR COMPANY LLC (“PARKSIDE LESSOR”) AND PARKSIDE OPERATING COMPANY LLC (“NEW OPERATOR”) February 28, 2019 TABLE OF CONTENTS 1.1Purchased Assets.2 1.2Excluded Assets.4 1.3Retained Liabilities.6 1.4Assumed Liabilities.6 1.5Inspections.7 1. |
|
| February 14, 2019 |
SSY / SunLink Health Systems, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYSTEM |
|
| December 13, 2018 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) December 13, 2018 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commis |
|
| December 13, 2018 |
SUNLINK HEALTH SYSTEMS, INC ANNOUNCES AMENDMENT TO ITS SHARE REPURCHASE PROGRAM EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC ANNOUNCES AMENDMENT TO ITS SHARE REPURCHASE PROGRAM Atlanta, GA (December 13, 2018) – – SunLink Health Systems, Inc. (NYSE: AMERICAN: SSY) today announced that, having purchased all the 300,000 shares authorized under its share repurchase progr |
|
| November 29, 2018 |
SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SHARE REPURCHASE PLAN EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SHARE REPURCHASE PLAN Atlanta, GA (November 29, 2018) — SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its Board of Directors had approved a share repurchase program that authorizes the Company to purchase up t |
|
| November 29, 2018 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 29, 2018 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (C |
|
| November 14, 2018 |
Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2018 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (C |
|
| November 14, 2018 |
SSY / SunLink Health Systems, Inc. FORM 10-Q (Quarterly Report) Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HE |
|
| October 15, 2018 |
SSY / SunLink Health Systems, Inc. / North Atlantic Value Llp - SCHEDULE 13D/A Activist Investment Schedule13D.DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* SunLink Health Systems, Inc. (Name of Issuer) Common Stock, without par value (Title of Class of Securities) 86737u102 (CUSIP Number) Ryan Corton Harwood Capital LLP 6 Stratton Street London W1J 8LD England 44 (0)20 7640 3202 (Name, Addr |
|
| October 15, 2018 |
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Scheduled 13D dated September 28, 2018 with respect to the shares of Common Stock, without par value, of Sunlink Health Systems, Inc. and any further amendments thereto executed by each or any of us shall be filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under th |
|
| October 15, 2018 |
Exhibit 99.2 00 Circle 75 Parkway, Suite 1120 Atlanta, Georgia 30399 770-933-7000 770-933-7010 Fax www. sunlinkhealth.com June 28, 2007 Mr. Christopher H.B. Mills Partner North Atlantic Value LLP 14 Ryder Street England Dear Christopher: I am pleased to advise you that the Board of Directors of SunLink Health Systems, Inc. is agreeable to electing you to serve as an eighth director commencing July |
|
| October 11, 2018 |
SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SALE OF MEDICAL OFFICE BUILDING AND LAND EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE NEWS RELEASE Contact: Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC ANNOUNCES SALE OF MEDICAL OFFICE BUILDING AND LAND Atlanta, GA (October 11, 2018) – – SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced the sale of a medical office building and approximately two adjacent acres of undeveloped la |
|
| October 11, 2018 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) October 11, 2018 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Co |
|
| September 27, 2018 |
SSY / SunLink Health Systems, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 25, 2018 |
EX-21.1 2 d622610dex211.htm EX-21.1 Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary SunLink Health Systems Technology, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of H |
|
| September 25, 2018 |
SSY / SunLink Health Systems, Inc. FORM 10-K (Annual Report) Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12607 SunLink Health Systems, I |
|
| May 11, 2018 |
SSY / SunLink Health Systems, Inc. 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH SYST |
|
| February 14, 2018 |
SSY / SunLink Health Systems, Inc. 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH S |
|
| February 14, 2018 |
EX-10.1 Exhibit 10.1 FIFTH AMENDMENT TO LOAN AGREEMENT, MODIFICATION OF NOTE AND WAIVER THIS FIFTH AMENDMENT TO LOAN AGREEMENT, MODIFICATION OF NOTE AND WAIVER (this “Amendment”) is dated as of December 26, 2017 (the “Effective Date”), among Southern Health Corporation of Houston, Inc., a Georgia corporation (“Borrower”), Crown Healthcare Investments, LLC, a Georgia limited liability company (f/k/ |
|
| February 9, 2018 |
SCHEDULE 13G JOINT FILING AGREEMENT Exhibit A Exhibit A SCHEDULE 13G JOINT FILING AGREEMENT In accordance with the requirements of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and subject to the limitations set forth therein, the parties set forth below agree to jointly file the Schedule 13G to which this joint filing agreement is attached, and have duly executed this joint filing agreement as of the date set forth below. |
|
| February 9, 2018 |
SC 13G 1 d538992dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 86737U102 (CUSIP Number) December 28, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropr |
|
| January 25, 2018 |
SSY / SunLink Health Systems, Inc. / Baileys Steven J - SC 13D/A Activist Investment SC 13D/A 1 d530794dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 11)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Steven J. Baileys 30691 Hunt Club Drive San Juan Capistrano, California 92675 (949) 425-4300 (Na |
|
| January 22, 2018 |
SSY / SunLink Health Systems, Inc. / Thornton Robert M Jr - SC 13D/A Activist Investment SC 13D/A 1 d528707dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Robert M. Thornton, Jr. 900 Circle 75 Parkway, Suite 1120 Atlanta, Georgia 30339 (7 |
|
| January 18, 2018 |
December 4, 2017 Robert M. Thornton, Jr. Chairman SunLink Health Systems, Inc. 900 Circle 75 Parkway, Suite 1120 Atlanta, Georgia 30339 Re: SunLink Health Systems, Inc. Schedule TO-I Schedule 13E-3 Filed November 21, 2017, by SunLink Health Systems, Inc. File No. 005-03600 Dear Mr. Thornton: We have limited our review of the filing to those issues we have addressed in our comments. In our comments |
|
| January 10, 2018 |
SSY / SunLink Health Systems, Inc. / Turner Howard E - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 SunLink Health Systems, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 867370102 (CUSIP Number) Howard E. Turner Smith, Gambrell & Russell, LLP 1230 Peachtree Street, Suite 3100 Promenade Atlanta, GA 30309 (404) 815-3594 (Name, Addre |
|
| December 28, 2017 |
Press Release dated December 28, 2017 announcing final results of the Tender Offer EX-99.(a)(5)(E) Exhibit (a)(5)(E) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FINAL RESULTS OF TENDER OFFER Atlanta, Georgia (December 28, 2017) – SunLink Health Systems, Inc. (NYSE:American: SSY) today announced the final results of its tender offer (the “Offer”) which expired at midnight, New York City Time, on December 21, 2 |
|
| December 28, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| December 22, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| December 22, 2017 |
Press Release dated December 22, 2017 announcing preliminary results of the Tender Offer. EX-99.(a)(5)(D) Exhibit (a) (5) (D) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES PRELIMINARY RESULTS FOR TENDER OFFER Atlanta, Georgia (December 22, 2017) – SunLink Health Systems, Inc. (NYSE:American: SSY) announced today the preliminary results of its tender offer (the “Offer”) which expired at midnight, New York City Time, on |
|
| December 7, 2017 |
SSY / SunLink Health Systems, Inc. ESP SEC Response Letter M. Timothy Elder Direct Tel: (404) 815-3532 December 7, 2017 Direct Fax: (404) 685-6832 [email protected] VIA EDGAR TRANSMISSION Nicholas P. Panos Senior Special Counsel Office of Mergers and Acquisitions Division of Corporate Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: SunLink Health Systems, Inc. Schedule TO-I Schedule 13E-3 Filed |
|
| December 7, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| November 21, 2017 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 21, 2017 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (C |
|
| November 21, 2017 |
EX-99.1 Exhibit 99.1 NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES INTENTION TO COMMENCE TENDER OFFER TO REPURCHASE UP TO 1,562,500 OF ITS COMMON SHARES Atlanta, Georgia (November 21, 2017) ? SunLink Health Systems, Inc. (NYSE: American: SSY) announced today that it intends to commence a cash tender offer within the next week to |
|
| November 21, 2017 |
EX-99.1 Exhibit 99.1 NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES INTENTION TO COMMENCE TENDER OFFER TO REPURCHASE UP TO 1,562,500 OF ITS COMMON SHARES Atlanta, Georgia (November 21, 2017) ? SunLink Health Systems, Inc. (NYSE: American: SSY) announced today that it intends to commence a cash tender offer within the next week to |
|
| November 21, 2017 |
SSY / SunLink Health Systems, Inc. FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 21, 2017 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (C |
|
| November 21, 2017 |
Form of Letter of Transmittal. Exhibit (a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Common Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| November 21, 2017 |
Exhibit (a)(1)(G) Exhibit (a)(1)(G) NOTICE OF WITHDRAWAL OF TENDER For Brokers, Dealers, Banks, Trust Companies and other Nominees and DTC Participants Regarding Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| November 21, 2017 |
Notice to Executive Officers and Directors of Blackout Period, dated November 9, 2017. Exhibit (a)(5)(A) EXHIBIT (a)(5)(A) MEMORANDUM To: Executive Officers and Directors of SunLink Health Systems, Inc. |
|
| November 21, 2017 |
Form of Letter to Brokers, Dealers, Banks, Trust Companies and Other Nominees. Exhibit (a)(1)(D) Exhibit (a)(1)(D) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $2,500,000 at a Per Share Purchase Price of $1.60 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT MIDNIGHT, NEW YORK CITY TIME, ON DECEMBER 21, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| November 21, 2017 |
Form of Notice of Withdrawal of Tender for Individual Investors Exhibit (a)(1)(F) Exhibit (a)(1)(F) NOTICE OF WITHDRAWAL OF TENDER FOR INDIVIDUAL INVESTORS (but not for Brokers, Dealers, Banks, Trust Companies and other Nominees and DTC Participants) Regarding Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| November 21, 2017 |
Exhibit (a)(1)(C) Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY To Tender Common Shares of SunLink Health Systems, Inc. |
|
| November 21, 2017 |
Offer to Purchase dated November 21, 2017. Exhibit (a)(1)(A) Exhibit (a)(1)(A) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $2,500,000 at a Per Share Purchase Price of $1.60 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT MIDNIGHT, NEW YORK CITY TIME, ON DECEMBER 21, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| November 21, 2017 |
Form of Letter to Clients for Use by Brokers, Dealers, Banks, Trust Companies and Other Nominees. Exhibit (a)(1)(E) Exhibit (a)(1)(E) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $2,500,000 at a Per Share Purchase Price of $1.60 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT MIDNIGHT, NEW YORK CITY TIME, ON DECEMBER 21, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| November 21, 2017 |
Press Release announcing commencement of the Tender Offer dated November 21, 2017. Exhibit (a)(5)(C) Exhibit (a)(5)(C) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES COMMENCEMENT OF TENDER OFFER TO REPURCHASE UP TO 1,562,500 OF ITS COMMON SHARES AT A PRICE OF $1.60 PER SHARE Atlanta, Georgia (November 21, 2017) – SunLink Health Systems, Inc. (NYSE: American: SSY) announced today that it has commenced a tender of |
|
| November 21, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I SC TO-I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title of Class of Securitie |
|
| November 16, 2017 |
Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported) November 13, 2017 SUNLINK HEALTH SYSTEMS, INC. (Exact Name Of Registrant As Specified In Charter) Ohio 1-12607 31-0621189 (State or other Jurisdiction of Incorporation) (Commis |
|
| November 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HE |
|
| September 29, 2017 |
SunLink Health Systems DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 28, 2017 |
Exhibit 21.1 LIST OF SUBSIDIARIES The direct and indirect subsidiaries of SunLink Health Systems, Inc. are listed below: Name of Subsidiary MedCare Services, Inc. SunLink ScriptsRx, LLC Crown Healthcare Investments, LLC (f/k/a MedCare South, LLC) New Seasons Assisted Living, LLC HealthMont LLC Dexter Hospital LLC Southern Health Corporation of Houston, Inc. Southern Health Corporation of Ellijay, |
|
| September 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEALTH |
|
| March 2, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 4 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| March 2, 2017 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FINAL RESULTS FOR TENDER OFFER Exhibit (a)(5)(F) Exhibit (a)(5)(F) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FINAL RESULTS FOR TENDER OFFER Atlanta, Georgia (March 2, 2017) SunLink Health Systems, Inc. (NYSE:MKT: SSY) today announced the final results of its tender offer (the Offer) which expired at 5:00 P.M., New York City Time, on February 24, 2017. |
|
| February 27, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| February 27, 2017 |
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES PRELIMINARY RESULTS FOR TENDER OFFER Exhibit (a)(5)(E) Exhibit (a)(5)(e) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES PRELIMINARY RESULTS FOR TENDER OFFER Atlanta, Georgia (February 27, 2017) – SunLink Health Systems, Inc. (NYSE:MKT: SSY) today announced the preliminary results of its tender offer (the “Offer”) which expired at 5:00 P.M., New York City Time, on Feb |
|
| February 14, 2017 |
EX-10.1 Exhibit 10.1 FOURTH AMENDMENT TO LOAN AGREEMENT AND WAIVER THIS FOURTH AMENDMENT TO LOAN AGREEMENT AND WAIVER (this “Amendment”) is dated as of January 6, 2017, among Southern Health Corporation of Houston, Inc., a Georgia corporation (“Borrower”), Crown Healthcare Investments, LLC, a Georgia limited liability company (f/k/a MedCare South, LLC) (“Crown”), SunLink Health Systems, Inc., an O |
|
| February 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12607 SUNLINK HEA |
|
| February 10, 2017 |
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SunLink Health Systems, Inc. (Name of Issuer) Common Shares, No Par Value (Title of Class of Securities) 86737U102 (CUSIP Number) March 15, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| February 9, 2017 |
Exhibit (a)(5)(D) Exhibit (a)(5)(D) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES EXTENSION OF TENDER OFFER TO REPURCHASE UP TO 3,000,000 OF ITS COMMON SHARES AT A PRICE OF $1.50 PER SHARE Atlanta, Georgia (February 9, 2017) – SunLink Health Systems, Inc. (NYSE:MKT: SSY) announced today that it has extended its previously announc |
|
| February 9, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| February 3, 2017 |
SSY / SunLink Health Systems, Inc. / Sunlink Health Systems Inc - SC TO-I/A SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE TO SCHEDULE 13E-3 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) or 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934. SUNLINK HEALTH SYSTEMS, INC. (Name Of Subject Company (Issuer)) SUNLINK HEALTH SYSTEMS, INC. (Name of Filing Persons (Issuer and Offeror)) Common Shares, no par value (Title |
|
| February 2, 2017 |
CORRESP M. Timothy Elder Direct Tel: (404) 815-3532 Direct Fax: (404) 685-6832 [email protected] February 2, 2017 VIA EDGAR TRANSMISSION Christina Chalk Senior Special Counsel Office of Mergers and Acquisitions Division of Corporate Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: SunLink Health Systems, Inc. Schedule TO-I/13E-3 filed January 10, 2017 File N |
|
| January 23, 2017 |
January 23, 2017 Via Email Howard E. Turner Smith, Gambrill & Russell, LLP Suite 3100, Promenade II 1230 Peachtree Street, NE Atlanta, Georgia 30309-3592 Re: Sunlink Health Systems, Inc. Schedule TO-I/13E-3 filed January 10, 2017 File No. 005-03600 Dear Mr. Turner: We have reviewed your filings referenced above and have the following comments. In some of our comments, we may ask you to provide us |
|
| January 10, 2017 |
Exhibit (a)(1)(G) Exhibit (a)(1)(G) NOTICE OF WITHDRAWAL OF TENDER For Brokers, Dealers, Banks, Trust Companies and other Nominees and DTC Participants Regarding Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(1)(D) Exhibit (a)(1)(D) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $4,500,000 at a Per Share Purchase Price of $1.50 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FEBRUARY 8, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| January 10, 2017 |
Exhibit (a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Common Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(5)(C) Exhibit (a)(5)(C) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES COMMENCEMENT OF TENDER OFFER TO REPURCHASE UP TO 3,000,000 OF ITS COMMON SHARES AT A PRICE OF $1.50 PER SHARE Atlanta, Georgia (January 10, 2017) – SunLink Health Systems, Inc. (NYSE:MKT: SSY) announced today that it has commenced a tender offer to |
|
| January 10, 2017 |
Exhibit (a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Common Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(5)(C) Exhibit (a)(5)(C) NEWS RELEASE Robert M. Thornton, Jr. Chief Executive Officer (770) 933-7004 SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES COMMENCEMENT OF TENDER OFFER TO REPURCHASE UP TO 3,000,000 OF ITS COMMON SHARES AT A PRICE OF $1.50 PER SHARE Atlanta, Georgia (January 10, 2017) – SunLink Health Systems, Inc. (NYSE:MKT: SSY) announced today that it has commenced a tender offer to |
|
| January 10, 2017 |
Exhibit (a)(1)(E) Exhibit (a)(1)(E) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $4,500,000 at a Per Share Purchase Price of $1.50 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FEBRUARY 8, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| January 10, 2017 |
Exhibit (a)(1)(G) Exhibit (a)(1)(G) NOTICE OF WITHDRAWAL OF TENDER For Brokers, Dealers, Banks, Trust Companies and other Nominees and DTC Participants Regarding Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(5)(A) EXHIBIT (a)(5)(A) MEMORANDUM To: Executive Officers and Directors of SunLink Health Systems, Inc. |
|
| January 10, 2017 |
Exhibit (a)(1)(F) Exhibit (a)(1)(F) NOTICE OF WITHDRAWAL OF TENDER FOR INDIVIDUAL INVESTORS (but not for Brokers, Dealers, Banks, Trust Companies and other Nominees and DTC Participants ) Regarding Shares of SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(1)(C) Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY To Tender Common Shares of SunLink Health Systems, Inc. |
|
| January 10, 2017 |
Exhibit (a)(1)(D) Exhibit (a)(1)(D) SUNLINK HEALTH SYSTEMS, INC. Offer to Purchase for Cash Common Shares for an Aggregate Purchase Price of Not More Than $4,500,000 at a Per Share Purchase Price of $1.50 Per Share THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FEBRUARY 8, 2017, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED, THE “EXP |
|
| January 10, 2017 |
Exhibit (a)(1)(A) Table of Contents Exhibit (a)(1)(A) SUNLINK HEALTH SYSTEMS, INC. |
|
| January 10, 2017 |
Exhibit (a)(1)(C) Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY To Tender Common Shares of SunLink Health Systems, Inc. |
